In March 2025, the company introduced new options for a direct-to-shopper presenting of its Wegovy weight loss drug. The company recognized a different pharmacy, called NovoCare, which might cost buyers $499 per 30 days for access to the drug, less than fifty percent the cost of the drug through other pharmaceutical distribution networks.[53]The fo